徕卡病理系统新闻动态

Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical trials, and through to routine diagnostics. Vista, CA, and Albuquerque, NM, January 8, 2025 –…

Fully automated SignalStar™ Multiplex IHC protocol on the BOND RX by Leica Biosystems eliminates hands-on time for streamlined image generation and analysis in two days Melbourne, Australia , November 4, 2024 – Leica Biosystems is pleased to announce a collaboration with Cell Signaling…

As a new partner of the Asian Society of Digital Pathology, Leica Biosystems now supports all three continental digital pathology societies. Seoul, South Korea – Leica Biosystems has announced its diamond partnership with the Asian Society of Digital Pathology (ASDP), making the company a sponsor…

Leica Biosystems’ new R&D facility will serve as a hub for collaborative research with leading pharmaceutical and academic institutions.  The center aims to speed and streamline the development and commercialization of companion diagnostics. NEWCASTLE UPON TYNE, July 23, 2024 – Leica…

Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care. This partnership enables automated in situ proximity ligation assays on…